Quanterix Corp (QTRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

900 MIDDLESEX TURNPIKE BILLERICA, MA 01821

Quanterix Corp. is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The companys digital health solution, Simoa gives the researchers the ability to closely examine the continuum from health to disease. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.

Data as of 2020-08-01
Market Cap914.728 Million Shares Outstanding28.311 Million Avg 30-day Volume237.964 Thousand
P/E Ratio Dividend Yield EPS-1.63
Price/Sales19.634 Price cash flow ratio Price free cash flow ratio-22.1
Book Value4.2 Price to Tangible Book9.68 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.344442
BETA1.80078 52-week High/Low35.7599 / 10.895 Stddev0.16351
View SEC Filings from QTRX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 84 24 (1.57%)
Aggregate 13F shares on 03/31/2020: 19.581 Million 5.404 Million
Aggregate 13F shares on 12/31/2019: 19.76 Million 5.566 Million
Percent change: -0.90% -2.92%
Funds creating new positions: 14 4
Funds Adding to an existing position: 31 12
Funds closing out their position: 12 8
Funds reducing their position: 25 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding QTRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QTRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

44.4 Thousand total shares from 27 transactions

Exercise Derivative Conversion (M)

17.8 Thousand total shares from 9 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

1,064,204 2020-07-21 30

MADAUS MARTIN D

176,162 2020-07-20 22

DUFFY DAVID C. SVP R&D AND CTO

47,858 2020-07-13 14

CRANDELL KEITH

3,959,418 2020-07-01 4

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

21,556 2020-07-01 18

MEISTER PAUL M

10,230 2020-07-01 4

MATTOON DAWN SR. VP, RESEARCH PRODUCTS

31,983 2020-07-01 13

CHAUBAL AMOL CHIEF FINANCIAL OFFICER

25,727 2020-07-01 3

FRY JOHN J GENERAL COUNSEL & SECRETARY

31,659 2020-07-01 3

HLAVINKA SARAH E.

8,441 2020-07-01 4

WALT DAVID R

  • Director
0 2020-06-04 2

COLE DOUGLAS G.

  • Director
0 2020-06-03 0

CONNOLLY JOHN M

9,510 2020-01-02 1

DEKKERS MARIJN E

34,429 2020-01-02 2

DESJOURDY AMEE CHIEF HUMAN RESOURCE OFFICER

  • Officer
11,834 2019-08-19 2

STREETER JACKSON SVP, CORP DEV & STRATEGY

32,515 2019-03-17 0

DRISCOLL JOSEPH CHIEF FINANCIAL OFFICER

4,388 2019-01-15 0

ORTICERIO ERNEST SVP FINANCE AND CORPORATE DEV

48,802 2019-01-09 0

BAL BRUCE J VP OF OPS, SERVICE AND QUALITY

  • Officer
5,485 2018-05-10 0

BAIN CAPITAL VENTURE INVESTORS, LLC

BAIN CAPITAL VENTURE PARTNERS 2005, L.P.

BAIN CAPITAL VENTURE FUND 2005, L.P.

BCIP ASSOCIATES III, LLC

BCIP ASSOCIATES III

BCIP ASSOCIATES III-B, LLC

BCIP ASSOCIATES III-B

KRUPKA MICHAEL A

AGARWAL AJAY

  • 10% Owner
2,136,085 2017-12-11 0

BIOMERIEUX/ADR

  • 10% Owner
2,055,632 2017-12-11 0

FLAGSHIP VENTURES FUND 2004 L P

FLAGSHIP VENTURES GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2017-12-11 0

ARCH VENTURE FUND VI LP

ARCH VENTURE FUND VIII OVERAGE, L.P.

ARCH VENTURE PARTNERS VI LP

ARCH VENTURE PARTNERS VI LLC

ARCH VENTURE PARTNERS VIII, LLC

BYBEE CLINTON

NELSEN ROBERT

  • 10% Owner
1,537,684 2017-12-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-07-21 S 2,636 $31.87 d 1,064,204 1,064,204.00 direct yes

MADAUS MARTIN D

2020-07-21 S 1,600 $31.45 d 11,196 176,162.00 direct yes

MADAUS MARTIN D

2020-07-21 M 1,600 d 10,507 176,162.00 direct

MADAUS MARTIN D

2020-07-21 M 1,600 $1.93 a 12,796 176,162.00 direct

MADAUS MARTIN D

2020-07-20 M 1,600 d 12,107 176,162.00 direct

MADAUS MARTIN D

2020-07-20 S 1,600 $31.05 d 11,196 176,162.00 direct yes

MADAUS MARTIN D

2020-07-20 M 1,600 $1.93 a 12,796 176,162.00 direct

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-07-16 S 4,500 $27.94 d 1,066,840 1,066,840.00 direct yes

DUFFY DAVID C. SVP R&D AND CTO

2020-07-13 S 1,667 $27.39 d 47,858 47,858.00 direct

MADAUS MARTIN D

2020-07-09 S 1,600 $26.85 d 11,196 176,162.00 direct yes

MADAUS MARTIN D

2020-07-09 M 1,600 d 13,707 176,162.00 direct

MADAUS MARTIN D

2020-07-09 M 1,600 $1.93 a 12,796 176,162.00 direct

MADAUS MARTIN D

2020-07-08 M 1,600 $1.93 a 12,796 176,162.00 direct

MADAUS MARTIN D

2020-07-08 M 1,600 d 15,307 176,162.00 direct

MADAUS MARTIN D

2020-07-08 S 1,600 $27.00 d 11,196 176,162.00 direct yes

CRANDELL KEITH

2020-07-01 A 422 $27.80 a 9,733 3,959,418.00 direct

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

2020-07-01 S 7 $27.45 d 21,556 21,556.00 direct

MATTOON DAWN SR. VP, RESEARCH PRODUCTS

2020-07-01 S 148 $26.83 d 31,994 31,983.00 direct

CHAUBAL AMOL CHIEF FINANCIAL OFFICER

2020-07-01 S 8 $27.45 d 25,727 25,727.00 direct

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-07-01 S 3,060 $26.83 d 1,071,577 1,071,340.00 direct

MADAUS MARTIN D

2020-07-01 A 651 $27.80 a 11,196 176,162.00 direct

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

2020-07-01 S 85 $26.83 d 21,563 21,556.00 direct

FRY JOHN J GENERAL COUNSEL & SECRETARY

2020-07-01 S 10 $27.45 d 31,659 31,659.00 direct

CHAUBAL AMOL CHIEF FINANCIAL OFFICER

2020-07-01 S 109 $26.83 d 25,735 25,727.00 direct

MEISTER PAUL M

2020-07-01 A 494 $27.80 a 10,230 10,230.00 direct

HLAVINKA SARAH E.

2020-07-01 A 359 $27.80 a 8,441 8,441.00 direct

MATTOON DAWN SR. VP, RESEARCH PRODUCTS

2020-07-01 S 11 $27.45 d 31,983 31,983.00 direct

FRY JOHN J GENERAL COUNSEL & SECRETARY

2020-07-01 S 134 $26.83 d 31,669 31,659.00 direct

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-07-01 S 237 $27.45 d 1,071,340 1,071,340.00 direct

MADAUS MARTIN D

2020-06-25 S 1,600 $26.08 d 10,545 175,511.00 direct yes

MADAUS MARTIN D

2020-06-25 M 1,600 d 16,907 175,511.00 direct

MADAUS MARTIN D

2020-06-25 M 1,600 $1.93 a 12,145 175,511.00 direct

MADAUS MARTIN D

2020-06-24 M 1,600 $1.93 a 12,145 175,511.00 direct

MADAUS MARTIN D

2020-06-24 M 1,600 d 18,507 175,511.00 direct

MADAUS MARTIN D

2020-06-24 S 1,600 $26.39 d 10,545 175,511.00 direct yes

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-06-23 S 5,000 $27.07 d 1,074,637 1,074,637.00 direct yes

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-06-18 S 5,060 $26.84 d 1,080,077 1,079,637.00 direct yes

HRUSOVSKY E KEVIN CHAIRMAN, PRESIDENT & CEO

2020-06-18 S 440 $27.32 d 1,079,637 1,079,637.00 direct yes

DUFFY DAVID C. SVP R&D AND CTO

2020-06-16 S 1,667 $26.35 d 49,525 49,525.00 direct

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

2020-06-15 S 5,000 $24.80 d 21,648 21,648.00 direct

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

2020-06-15 M 5,000 $2.96 a 26,648 21,648.00 direct

ROSKEY MARK T. SVP, COMMERCIAL & ACCELERATOR

2020-06-15 M 5,000 d 94,455 21,648.00 direct

FRY JOHN J GENERAL COUNSEL & SECRETARY

2020-06-11 S 1,842 $24.77 d 31,803 31,803.00 direct

MADAUS MARTIN D

2020-06-09 M 1,600 d 20,107 175,511.00 direct

MADAUS MARTIN D

2020-06-09 M 1,600 $1.93 a 12,145 175,511.00 direct

MADAUS MARTIN D

2020-06-09 S 1,600 $25.37 d 10,545 175,511.00 direct yes

MADAUS MARTIN D

2020-06-08 M 1,600 $1.93 a 12,145 175,511.00 direct

MADAUS MARTIN D

2020-06-08 M 1,600 d 21,707 175,511.00 direct

MADAUS MARTIN D

2020-06-08 S 1,600 $25.90 d 10,545 175,511.00 direct yes
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments